Your partner in radiopharmacy

Since 2004, Trasis designs, manufactures,  sells and supports high performance synthesizers, dose preparation and dispensing equipment, all related consumables and shielding solutions

Products

Helping the medical community easily access new radiolabeled therapeutic and diagnostic substances.

Our nuclear medicine equipment includes automated synthesizers, dose dispensing systems, their shielding and accessories. We also develop customized synthetic methods and instruments adapted to the evolving needs of the radiochemistry industry.

Our equipment is used worldwide in nuclear medicine departments, research centers, radiopharmaceutical production facilities and pharmaceutical companies.

See all products

About us

In a  nutshell: designer and manufacturer of radiopharma instruments, ISO 9001-certified company, medical device distributor, close to its customers and partners.

What makes us different: we consider our customers' performance as our own and we put everything in place to improve it.

Our strength:  every aspect of our products: design, manufacturing, commercial service, quality and support is under our full control. Our great multidisciplinary team makes this possible.

Our final goal: enable patients to have access to a wide range of radiotracers in the safest and most timely manner.

Read more

Innovating for nuclear medicine

We develop innovating equipment which enables safe manipulation and quick access to radiolabeled therapeutic and diagnostic substances.

Nuclear Medecine  departements

Drug developers

Drug developers

Nuclear medicine departments

Drug manufacturers

Drug manufacturers

After sales services
After Sales services
Mail US
support_trasis [at] trasis [dot] com

News & Events

PRESS RELEASE: [18F]FDG Dual radiotracer approved by FDA

Trasis and Shertech Laboratories, received FDA approval of the [18F]FDG Dual process on AllinOne synthesizers.

Trasis and Shertech Laboratories “hand to hand” work was recently rewarded with approval of a supplemental abbreviated New Drug Application and thus receiving a Marketing Authorization from the U.S. Food and Drug Administration for the [18F]FDG Dual process on AllinOne modules.

What a human size partner can do at the SNMMI that others can't ?

#1 Welcoming people on a cosy and peaceful booth while sharing a piece of belgian chocolate

That's true ! As a Belgian company, we shall never forget to bring a little of our heritage with us. It's important for us that people worldwide know Belgium not only as the country where state of the art synthesizers can be found but also as the place to be for specialties as chocolate, beers or french fries.

Scientific Publications

Key facts

>35
Global partners
>30
Approved or demonstrated tracers
90%
exposure reduction
10 Years
Extended warranty for dispensers